
In a win for the Make America Healthy Again (MAHA) movement, the Advisory Committee on Immunization Practices (ACIP) voted 5-1 to limit flu vaccines to only those free of thimerosal. The mercury-containing preservative, largely phased out of childhood vaccines by 2001, still lingers in some multi-dose flu shots. But with 96% of U.S. flu vaccines for the 2024-2025 season already thimerosal-free, single-dose options are not hard to come by.
The committee, freshly revamped by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., also voted 5-1 to mandate thimerosal-free flu vaccines for children 18 and under and pregnant women.
The effort to remove thimerosal began in the late 1990s, sparked by growing public and scientific scrutiny of mercury exposure. In 1997, the FDA Modernization Act prompted a review of mercury in medical products, including thimerosal, a mercury-based preservative used since the 1930s to prevent microbial contamination in multi-dose vaccine vials.
Vaccine skeptics get a voice in health policy
Now at the helm of the Department of Health and Human Services, Kennedy rattled the establishment medical world in early June when he replaced all 17 ACIP members with a leaner crew of eight, including vaccine skeptics like Dr. Robert Malone and Lyn Redwood, former head of Kennedy’s Children’s Health Defense, an anti-vaccine group. Redwood’s plea to reject thimerosal wasn’t flawless—she overstated its common dosages—but the committee leaned into the mercury-free messaging. “There are other preservatives that don’t rely on mercury,” Dr. Jacob Glanville, CEO of Centivax, told Fox News Digital with a nod of approval.
Click this link for the original source of this article.
Author: Ray Hilbrich
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.